.png){kind=small}
2016
Study about the Efficacy of Metformin to Immune Function in Cancer Patients
Watanabe M, Yamamoto H, Eikawa S, Shien K, Shien T, Soh J, Hotta K, Wada J, Hinotsu S, Fujiwara T, Kiura K, Doihara H, Miyoshi S, Udono H, Toyooka S
Acta medica Okayama. 70:327-30
A Phase I Trial of 100 mg/m2 Docetaxel in Patients with Advanced or Recurrent Breast Cancer. Acta medica Okayama
Tamura T, Hirata T, Tabata M, Hinotsu S, Hamada A, Motoki T, Iwamoto T, Mizoo T, Nogami T, Shien T, Taira N, Matsuoka J, Doihara H.
Acta medica Okayama. 70:425-7
A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer
Hadad SM, Jordan LB, Roy PG, Purdie CA, Iwamoto T, Pusztai L, Moulder-Thompson SL, Thompson AM.
BMC Cancer. 2016;16:745
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition
Taira N, Arai M, Ikeda M, Iwasaki M, Okamura H, Takamatsu K, Nomura T, Yamamoto S, Ito Y, Mukai H.
Breast cancer. 23:343-56
Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004
Kinoshita T, Fukui N, Anan K, Iwamoto T, Niikura N, Kawai M, Hayashi N, Tsugawa K, Aogi K, Ishida T, Masuoka H, Masuda S, Iijima K, Nakamura S, Tokuda Y
Breast cancer. 23:39-49
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer
Yamashita H, Ogiya A, Shien T, Horimoto Y, Masuda N, Inao T, Osako T, Takahashi M, Endo Y, Hosoda M, Ishida N, Horii R, Yamazaki K, Miyoshi Y, Yasojima H, Tomioka N, Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Breast cancer. 23:830-43
Assessment of the Ki67 labeling index: a Japanese validation ring study
Niikura N, Sakatani T, Arima N, Ohi Y, Honma N, Kanomata N, Yoshida K, Kadoya T, Tamaki K, Kumaki N, Iwamoto T, Sugie T, Moriya T
Breast cancer. 23:92-100
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Ogiya A, Yamazaki K, Horii R, Shien T, Horimoto Y, Masuda N, Inao T, Hosoda M, Ishida N, Osako T, Takahashi M, Endo Y, Miyoshi Y, Yasojima H, Tomioka N, Yamashita H, Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Breast cancer. 23:
Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S, Yamauchi C, Komoike Y, Tsugawa K, Yotsumoto D, Wada N, Ueno T, Oba MS, Shien T, Sugae S, Tsuda H, Yoneyama K.
Breast cancer. 23:
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
Iwamoto T, Kumamaru H, Miyata H, Tomotaki A, Niikura N, Kawai M, Anan K, Hayashi N, Masuda S, Tsugawa K, Aogi K, Ishida T, Masuoka H, Iijima K, Matsuoka J, Doihara H, Kinoshita T, Nakamura S, Tokuda Y
Breast Cancer Res Treat. 156:485-94
Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
Kataoka A, Iwamoto T, Tokunaga E, Tomotaki A, Kumamaru H, Miyata H, Niikura N, Kawai M, Anan K, Hayashi N, Masuda S, Tsugawa K, Aogi K, Ishida T, Masuoka H, Iijima K, Kinoshita T, Nakamura S, Tokuda Y
Breast Cancer Res Treat. 160:163-72
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence
Miyoshi Y, Shien T, Ogiya A, Ishida N, Yamazaki K, Horii R, Horimoto Y, Masuda N, Yasojima H, Inao T, Osako T, Takahashi M, Tomioka N, Endo Y, Hosoda M, Doihara H, Miyoshi S, Yamashita H, Collaborative Study Group of Scientific Research of the Japanese Breast Cancer S
Breast cancer research. 18:73
A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer
Yoshitomi S, Taira N, Doihara H, Mizoo T, Nogami T, Iwamoto T, Motoki T, Shien T, Ogasawara Y, Matsuoka J, Tsuji H, Mitsuhashi T
Cancer chemotherapy and pharmacology. 78:289-94
Comparison of Tumour-infiltrating Lymphocytes between Primary and Metastatic Tumours in Breast Cancer Patients
Ogiya R, Niikura N, Kumaki N, Bianchini G, Kitano S, Iwamoto T, Hayashi N, Yokoyama K, Oshitanai R, Terao M, Morioka T, Tsuda B, Okamura T, Saito Y, Suzuki Y, Tokuda Y.
Cancer Sci. 107:1730-5
Breast Cancer Metastasis to the Stomach That Was Diagnosed after Endoscopic Submucosal Dissection
Kita M, Furukawa M, Iwamuro M, Hori K, Kawahara Y, Taira N, Nogami T, Shien T, Tanaka T, Doihara H, Okada H
Case reports in gastrointestinal medicine. 2085452
Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.
Yoshida A, Takahashi O, Okumura Y, Arima N, Nakatsukasa K, Tanabe M, Shien T, Masuda N, Tanaka S, Komoike Y, Taguchi T, Iwase T, Nishimura R, Inaji H, Yamauchi H, Ishitobi M
Eur J Surg Oncol. 42:474-80
Local recurrence risk after previous salvage mastectomy
Tanabe M, Iwase T, Okumura Y, Yoshida A, Masuda N, Nakatsukasa K, Shien T, Tanaka S, Komoike Y, Taguchi T, Arima N, Nishimura R, Inaji H, Ishitobi M; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society..
Eur J Surg Oncol. 42:980-5
Cohort Study of Secondary Endocrine Therapy in Metastatic Breast Cancer with a Poor Response to Initial Endocrine Therapy
Taira N, Fujisawa T, Araki K, Iwamoto T, Sakamaki K, Takahashi M, Aihara T, Mukai H
J Clin Trials. 6:2
Randomized, Optimal Dose Finding, Phase Ii Study of Tri-Weekly NabPaclitaxel in Patients with Metastatic Breast Cancer (ABROAD)
Fumikata Hara, Tsutomu Takashima, Junji Tsurutani, Tsuyoshi Saito, Naruto Taira, Kosuke Kashiwabara, Tomohiko Aihara, Hirofumi Mukai
J Clin Trials . 6:267
Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report
Otsuka M, Yamasaki O, Kaji T, Shien T, Iwatsuki K
JAMA dermatology. 152:111-3
A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer
Kashiwaba M, Ito Y, Takao S, Doihara H, Rai Y, Kanatani K, Takashima S, Masuda N
Japanese journal of clinical oncology. 46:407-14
2015
Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer:NACED-Randomized Multicenter Phase II Trial
Sugiu K, Iwamoto T, Kelly CM, Watanabe N, Motoki T, Ito M, Ohtani S, Higaki K, Imada T, Yuasa T, Omori M, Sonobe H, Fujiwara T, Matsuoka J.
Acta Med Okayama. 69:291-9
Correlation between 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal Carcinoma of the Breast.
Ito M, Shien T, Kaji M, Mizoo T, Iwamoto T, Nogami T, Motoki T, Taira N, Doihara H, Miyoshi S.
Acta Med Okayama. 69:338-8
Changes in Tumor Expression of HER2 and Hormone Receptors Status after Neoadjuvant Chemotherapy in 21,755 Patients from the Japanese Breast Cancer Registry
Niikura N, Tomotaki A, Miyata H, Iwamoto T, Kawai M, Anan K, Hayashi N, Aogi K, Ishida T, Masuoka H, Iijima K, Masuda S, Tsugawa K, Kinoshita T, Nakamura S, Tokuda Y.
Ann Oncol. 27(3):480-8
The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer.
Taira N, Arai M, Ikeda M, Iwasaki M, Okamura H, Takamatsu K, Yamamoto S, Ohsumi S, Mukai H; Japanese Breast Cancer Society.
Breast Cancer. 22: 16-27
Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor
Ito M，Shien T，Omori M，Mizoo T，Iwamoto T，Nogami T，Motoki T，Taira N，Doihara H，Miyoshi S
Breast Cancer. 23:437-44
Comprehensive prognostic report of the Japanese Breast Cancer Society registry in 2006
Iwamoto T, Fukui N, Kinoshita T, Anan K, Niikura N, Kawai M, Hayashi N, Tsugawa K, Aogi K, Ishida T, Masuoka H, Masuda S, Iijima K, Nakamura S, Tokuda Y.
Breast Cancer. Oct 13. Epub ahead of print
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Yamashita H, Ogiya A, Shien T, Horimoto Y, Masuda N, Inao T, Osako T, Takahashi M, Endo Y, Hosoda M, Ishida N, Horii R, Yamazaki K, Miyoshi Y, Yasojima H, Tomioka N; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.
Breast Cancer. Oct. 14 Epub ahead of print
Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan
Miyashita M，Ohno S，Kataoka A，Tokunaga E，Masuda N，Shien T，Kawabata K，Takahashi M
Cancer Nurs. 38: E1-11
Relative Prognostic and Predictive Value of Gene Signature and Histologic Grade in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Iwamoto T, Kelly C, Mizoo T, Nogami T, Motoki T, Shien T, Taira N, Hayashi N, Niikura N, Fujiwara T, Doihara H, Matsuoka J.
Clin Breast Cancer. 16:95-100
Subtype specific metagene-based prediction of outcome after neoadjuvant and adjuvant treatment in breast cancer.
Callari M, Cappelletti V, D'Aiuto F, Musella V, Lembo A, Petel F, Karn T, Iwamoto T, Provero P, Daidone MG, Gianni L, Bianchini G.
Clin Cancer Res. 22: 337-45
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence
Okumura Y，Nishimura R，Nakatsukasa K，Yoshida A，Masuda N，Tanabe M，Shien T，Tanaka S，Arima N，Komoike Y，Taguchi T，Iwase T，Inaji H，Ishitobi M
Eur J Surg Oncol. 41：548-552
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Kondo T, Hayashi N, Ohde S, Suzuki K, Yoshida A, Yagata H, Niikura N, Iwamoto T, Kida K, Murai M, Takahashi Y, Tsunoda H, Nakamura S, Yamauchi H.
J Surg Oncol. 112: 476-80
Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy： A Case Report
Otsuka M，Yamasaki O，Kaji T，Shien T，Iwatsuki K
JAMA Dermatol. 152(1):111-3
Executive Committee for the Setouchi Breast Cancer Cohort Study：Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis： the Setouchi Breast Cancer Cohort Study
Taira N，Akiyama I，Ishihara S，Ishibe Y，Kawasaki K，Saito M，Shien T，Nomura T，Hara F，Mizoo T，Mizota Y，Yamamoto S，Ohsumi S，Doihara H
Jpn J Clin Oncol. 45：600-2
2014
p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancer.
Shien T, Kinoshita T, Seki K, Yoshida M, Hojo T, Shimizu C, Taira N, Doihara H, Akashi-Tanaka S, Tsuda H, Fujiwara Y.
Acta Med Okayama. 67:165-70. 2014
Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival.
Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, Viens P, Symmans WF, Birnbaum D, Van Laere SJ.
Ann Oncol 25:358-65. 2014
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
Masuda H, Brewer TM, Liu DD, Iwamoto T, Shen Y, Hsu L, Willey JS, Gonzalez-Angulo AM, Chavez-MacGregor M, Fouad TM, Woodward WA, Reuben JM, Valero V, Alvarez RH, Hortobagyi GN, Ueno NT.
Ann Oncol 25:384-91. 2014
Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases. Breast Cancer.
"Nogami T, Shien T, Tanaka T, Nishiyama K, Mizoo T, Iwamto T, Ikeda H, Taira N, Doihara H, Miyoshi S."
Breast Cancer. 21:58-65. 2014
Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies.
Ohsumi S, Taira N, Takabatake D, Takashima S, Hara F, Takahashi M, Kiyoto S, Aogi K, Nishimura R.
Breast Cancer 21:123-7. 2014
Impact of preservation of the intercostobrachial nerve during axillary dissection on sensory change and health-related quality of life 2 years after breast cancer surgery.
Taira N, Shimozuma K, Ohsumi S, Kuroi K, Shiroiwa T, Watanabe T, Saito M.
Breast Cancer 21:183-90. 2014
Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study.
Kataoka A, Tokunaga E, Masuda N, Shien T, Kawabata K, Miyashita M.
Breast Cancer. 21:643-50. 2014
Fertility preservation in breast cancer patients.
Shien T, Nakatsuka M, Doihara H.
Breast Cancer 21:651-5. 2014
The discordance between primary breast cancer lesions and pulmonary metastatic lesions in expression of aldehyde dehydrogenase1-positive cancer cells.
"Nogami T, Shien T, Tanaka T, Doihara H, Taira N, Takabatake D, Nishimura R, Nishiyama K, Mizoo T, Ohsumi S. "
Breast Cancer. 21:698-702. 2014
Assessment of the Ki67 labeling index: a Japanese validation ring study
Niikura N, Sakatani T, Arima N, Ohi Y, Honma N, Kanomata N, Yoshida K, Kadoya T, Tamaki K, Kumaki N, Iwamoto T, Sugie T, Moriya T. Assessment of the Ki67 labeling index: a Japanese validation ring study
Breast Cancer
Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer.
Taira N, Iwata H, Hasegawa Y, Sakai T, Higaki K, Kihara K, Yamaguchi T, Ohsumi S, Shimozuma K, Ohashi Y.
Breast Cancer Res Treat 145：155-64. 2014
Safety analysis of two different regimens of uracil-tegafur plus leucovorin as adjuvant chemotherapy for high-risk stage II and III colon cancer in a phase III trial comparing 6 with 18 months of treatment: JFMC33-0502 trial.
Tsuchiya T, Sadahiro S, Sasaki K, Kondo K, Katsumata K, Nishimura G, Kakeji Y, Baba H, Morita T, Koda K, Sato S, Matsuoka J, Yamaguchi Y, Usuki H, Hamada C, Kodaira S, Saji S.
Cancer Chemother Pharmacol. 73:1253-61.2014
Prognostic significance of the ki67 scoring categories in breast cancer subgroups. Clin Breast Cancer
Niikura N, Masuda S, Kumaki N, Xiaoyan T, Terada M, Terao M, Iwamoto T, Oshitanai R, Morioka T, Tuda B, Okamura T, Saito Y, Suzuki Y, Tokuda Y.
Clin Breast Cancer 14:323-9 e3. 2014
Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401).
Shien T, Iwata H, Aogi K, Fukutomi T, Inoue K, Kinoshita T, Takahashi M, Matsui A, Shibata T, Fukuda H.
Int J Clin Oncol. 19:982-8. 2014
Utility of the Singapore nomogram for predicting recurrence-free survival in Japanese women with breast phyllodes tumours.
Nishimura R, Tan PH, Thike AA, Tan MH, Taira N, Li HH, Ohsumi S.
J Clin Pathol 67:748-50. 2014
Fertility concerns and preservation strategies in young women with breast cancer.
Shien T.
J Thorac Dis. 6:581-3. 2014
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers.
Gyorffy B, Bottai G, Lehmann-Che J, Keri G, Orfi L, Iwamoto T, Desmedt C, Bianchini G, Turner NC, de The H, Andre F, Sotiriou C, Hortobagyi GN, Di Leo A, Pusztai L, Santarpia L.
Mol Oncol 8:508-19. 2014
Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells
Kai K, Iwamoto T, Kobayashi T, Arima Y, Takamoto Y, Ohnishi N, Bartholomeusz C, Horii R, Akiyama F, Hortobagyi GN, Pusztai L, Saya H, Ueno NT
Oncogene 33:440-8. 2014
Resection of the primary tumor in stage IV breast cancer.
Shien T, Doihara H.
World J Clin Oncol. 5:82-5. 2014
転移診断の検討
土井原博義
岡山医学会雑誌 126：25-30. 2014
早期乳癌におけるOne-step Nucleic Acid Amplification(OSNA)法によるセンチネルリンパ節 乳がん診療の質の向上を目指して
溝尾妙子，枝園忠彦，伊藤麻衣子，野上智弘，岩本高行，元木崇之，平成人，松岡順治，土井原 博義.
岡山医学会雑誌 126: 25-30. 2014
乳がん検診の現状
土井原博義
岡山県医師会報 1385：34-36. 2014
2013
Association between mammographic breast density and lifestyle in Japanese women.
Ishihara S, Taira N, Kawasaki K, Ishibe Y, Mizoo T, Shien T, Doihara H, Kanazawa S .
Acta Med Okayama. 67:145-51. 2013
p53 expression in pretreatment specimen predicts response to neoadjuvant chemotherapy including anthracycline and taxane in patients with primary breast cancer.
Shien T， Kinoshita T， Seki K，Yoshida M，Hojo T，Shimizu C，Taira N， Doihara H，Tanaka S， Tsuda H，Fujiwara Y
Acta Med Okayama. 67:167-170. 2013
Breast cancer subtype and distant recurrence after ipsilateral breast tumor recurrence.
Ishitobi M, Okumura Y, Arima N, Yoshida A, Nakatsukasa K, Iwase T, Shien T, Masuda N, Tanaka S, Tanabe M, Tanaka T, Komoike Y, Taguchi T, Nishimura R, Inaji H.
Ann Surg Oncol. 20:1886-92. 2013
Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women.
Mizoo T, Taira N, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Komoike Y, Miyoshi S.
BMC Cancer. 13,565. 2013
Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment.
Niikura N, Kimura M, Iwamoto T, Hayashi N, Shintoku J, Saito Y, Suzuki Y, Tokuda Y.
Breast Cancer. 20:67-74. 2013
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast0conserving surgery: the impact of radiotherapy on second IBTR.
Ishitobi M, Okumura Y, Nishimura R, Nakatsukasa K, Tanabe M, Yoshida A, Masuda N, Shien T, Tanaka S, Komoike Y, Arima N, Taguchi T, Inaji H; Collaborative StudyGroup of Scientific Research of the Japanese Breast Cancer Society.
Breast Cancer. 21:754-60. 2013
Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.
Bianchini G, Pusztai L, Karn T, Iwamoto T, Rody A, Kelly CM, Muller V, Schmidt M, Qi Y, Holtrich U, Becker S, Santarpia L, Fasolo A, Del Conte G, Zambetti M, Sotiriou C, Haibe-Kains B, Symmans WF, Gianni L.
Breast Cancer Res. 15:R86. 2013
Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers.
Masuda H, Baggerly KA, Wang Y, Iwamoto T, Brewer T, Pusztai L, Kai K, Kogawa T, Finetti P, Birnbaum D, Dirix L, Woodward WA, Reuben JM, Krishnamurthy S, Symmans WF, Van Laere SJ, Bertucci F, Hortobagyi GN, Ueno NT.
Breast Cancer Res. 15:R112. 2013
A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories.
Szekely B, Iwamoto T, Szasz AM, Qi Y, Matsuoka J, Symmans WF, Tokes AM, Kulka J, Swanton C, Pusztai L.
Breast Cancer Res Treat. 138:691-8. 2013
Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M, Iwamoto T, Matsuoka J, Nogami T, Motoki T, Shien T, Taira N, Niikura N, Hayashi N, Ohtani S, Higaki K, Fujiwara T, Doihara H, Symmans WF, Pusztai L.
Breast Cancer Res Treat. 143:403-9. 2013
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.
Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas CH, Hortobagyi GN, Rouzier R, Esteva FJ, Pusztai L.
Br J Cancer. 108:285-91. 2013
Statin use in primary inflammatory breast cancer: a cohort study.
Brewer TM, Masuda H, Liu DD, Shen Y, Liu P, Iwamoto T, Kai K, Barnett CM, Woodward WA, Reuben JM, Yang P, Hortobagyi GN, Ueno NT.
Br J Cancer. 109:318-24. 2013
TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase.
Wang X, Saso H, Iwamoto T, Xia W, Gong Y, Pusztai L, Woodward WA, Reuben JM, Warner SL, Bearss DJ, Hortobagyi GN, Hung MC, Ueno NT.
Cancer Res. 73:6516-25. 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets.
Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, Dirix L, Reuben JM, Bertucci F.
Clin Cancer Res. 19:4685-96. 2013
DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
Santarpia L, Iwamoto T, Di Leo A, Hayashi N, Bottai G, Stampfer M, Andre F, Turner NC, Symmans WF, Hortobagyi GN, Pusztai L, Bianchini G.
Oncologist. 18:1063-73. 2013
Bayesian Mixture Models for Assessment of Gene Differential Behaviour and Prediction of pCR through the Integration of Copy Number and Gene Expression Data.
Trentini F, Ji Y, Iwamoto T, Qi Y, Pusztai L, Muller P.
PLoS One. 8:e68071. 2013
乳癌と分子標的薬
土井原博義
岡山医学会雑誌 125:243-50. 2013
StageⅣ乳癌に対する原発巣切除の意義について
枝園忠彦，土井原博義
Bressance 14-15. 2013
がん手術療法の変遷・ 発展と手術患者QOL～乳がん手術療法を中心に～
土井原博義
がん看護 19:106-110. 2013